Adma Biologics (ADMA) Amortization - Intangibles (2017 - 2025)
Historic Amortization - Intangibles for Adma Biologics (ADMA) over the last 9 years, with Q3 2025 value amounting to $38000.0.
- Adma Biologics' Amortization - Intangibles rose 3571.43% to $38000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $132000.0, marking a year-over-year decrease of 7600.0%. This contributed to the annual value of $400000.0 for FY2024, which is 4475.14% down from last year.
- Per Adma Biologics' latest filing, its Amortization - Intangibles stood at $38000.0 for Q3 2025, which was up 3571.43% from $32000.0 recorded in Q2 2025.
- In the past 5 years, Adma Biologics' Amortization - Intangibles ranged from a high of $200000.0 in Q1 2021 and a low of $25000.0 during Q1 2025
- Over the past 5 years, Adma Biologics' median Amortization - Intangibles value was $193000.0 (recorded in 2024), while the average stood at $149419.6.
- Examining YoY changes over the last 5 years, Adma Biologics' Amortization - Intangibles showed a top increase of 3571.43% in 2025 and a maximum decrease of 8704.66% in 2025.
- Over the past 5 years, Adma Biologics' Amortization - Intangibles (Quarter) stood at $178486.0 in 2021, then changed by 0.0% to $178486.0 in 2022, then grew by 4.77% to $187000.0 in 2023, then plummeted by 80.21% to $37000.0 in 2024, then grew by 2.7% to $38000.0 in 2025.
- Its Amortization - Intangibles stands at $38000.0 for Q3 2025, versus $32000.0 for Q2 2025 and $25000.0 for Q1 2025.